Γρ. Σαράντης ΑΒΕΕ
Greece · GRS204003008 · reports in EUR · Europe
The answers
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Is it growing?Fair
- Revenue −0.1% in the year to Dec 31, 2025, on the year before.
- Is it a good business?Fair
- It earned 13% on its shareholders' equity in the year to Dec 31, 2025.
- Is it safe?Good
- Equity is 63% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in EUR.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | €445M | €482M | €600M | €600M |
| Operating profit | €32M | €47M | €61M | €67M |
| Net profit to shareholders | €26M | €39M | €46M | €53M |
| Earnings per share | €0.39 | €0.59 | €0.71 | €0.83 |
| Cash from operations | €23M | €59M | €62M | €77M |
| Cash | €61M | €111M | €47M | €63M |
| Total assets | €500M | €554M | €600M | €634M |
| Equity | €331M | €354M | €375M | €401M |
What they do
In the company's own words, from the annual report.
Αντικείμενο δραστηριότητας Ο Όμιλος δραστηριοποιείται στην παραγωγή και εμπορία καλλυντικών ειδών, ειδών οικιακής χρήσης και φαρμακευτικών ειδών. Οι κύριες δραστηριότητες του Ομίλου δεν έχουν αλλάξει σε σχέση με την προηγούμενη χρήση.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.